reference/31867581

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31867581

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	2624
issn	0008-5472 1538-7445
issueIdentifier	14
pageRange	2610-2624
publicationName	Cancer Research
startingPage	2610
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_577b665b648a57409f6c77b457f30f1a
bibliographicCitation	Panowski SH, Srinivasan S, Tan N, Tacheva-Grigorova SK, Smith B, Mak YSL, Ning H, Villanueva J, Wijewarnasuriya D, Lang S, Melton Z, Ghosh A, Dusseaux M, Galetto R, Heyen JR, Sai T, Van Blarcom T, Chaparro-Riggers J, Sasu BJ. Preclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma. Cancer Res. 2022 Jul 18;82(14):2610–24. doi: 10.1158/0008-5472.can-21-2931. PMID: 35294525.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_42a10f5d904044f53ee2588d84e92da5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7488-3086 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc9ec29b698e85214d4adeea07902bac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e56da11b50df67177cc48aac1c7e2c29 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd1848ae26c63ad7faca229df33fda7d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7fb32504446d8b46c86e8eddfb6dc404 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_38f0b0310f43c5fedf1bed6a22e277b2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c3e7c3cd085d845d40f2e918f547b7d http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5403-966X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3748db9069addc83654401c635499e95 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_353f2c55f6a43715cd1b88c3a6730243 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_56bda7bdc6de2c3eaff36b520a09faf9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4b5a68b09d0d68c9c729109e87a3291 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c06c1d559c679196e6bd1873da0121d0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0111-1661 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4394-7339 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5fa11446483999a5cde9d9d324ff6cb0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_41dfd5b958bd9b43a87810ba3dbfe6a7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8484d1aee6b28e9f0fecdc208a9b7b61
date	2022-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/35294525 https://doi.org/10.1158/0008-5472.can-21-2931
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2786 https://portal.issn.org/resource/ISSN/1538-7445 https://portal.issn.org/resource/ISSN/0008-5472
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Preclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma
discusses	http://id.nlm.nih.gov/mesh/M0492286 http://id.nlm.nih.gov/mesh/M0216394
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D007680Q000473 http://id.nlm.nih.gov/mesh/D002292Q000473 http://id.nlm.nih.gov/mesh/D018380
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D023041 http://id.nlm.nih.gov/mesh/D008252 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D016219 http://id.nlm.nih.gov/mesh/D053282 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D013601Q000378
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_118dd6abf266102dccb53d8fc658affb http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7170 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_32e9a27411fa801606447fe5863a602f

Total number of triples: 58.